Biopôle news

Oncosema and the STC Finder consortium awarded by the Lyon Auvergne-Rhône-Alpes Cancéropole.

Horée Raises 330,000 Euros and continues Its Breakthrough in the Cosmetic Industry.

Meet-up Pharma, a Day Dedicated to Health Industry Careers in Auvergne, will be Held on October 12th in Clermont-Ferrand.

Greentech Acquires the Plant Extraction Activities of Laboratoire Gifrer.

Verdot invests 10 million euros at the Biopôle Clermont-Limagne.

Eric Portier, new président of the Biopôle Clermont-Limagne Unrestricted Public Sector Association.

Valbiotis to launch its 100% natural dietary supplement for the management of hypercholesterolemia on the French market in May.

Alphanosos announces international partnership with Eurofragance.

“Accelerate your plant innovation!” VEGEPOLYS VALLEY launches the 8th edition of its contest dedicated to startups.

ONCOSEMA EST LAURÉATE DU CONCOURS DE L’INNOVATION I-LAB.

Sabi Agri launches ZILUS, its 100% electric oll-terrain robot.

Valbiotis annonce le large succès de l’étude clinique de Phase II/III internationale multicentrique REVERSE-IT sur TOTUM•63 qui démontre son efficacité sur le principal facteur de risque du diabète de type 2.

The Riom La Varenne pharmaceutical site is part of the SMO Biopôle Clermont-Limagne for now 10 years.

The SMO Biopôle Clermont-Limagne publishes its panorama and key figures for 2022.

Inauguration of the new Carbogen AMCIS production unit on the Biopôle Clermont-Limagne.

SABI AGRI raises €8 million to become a leader in agroecological robotics.

Intestinal microbiota: Valbiotis Research signes a research partnership with the MEDIS2 Unit from the Clermont Auvergne University.

It is good to live and work at Biopôle Clermont-Limagne!

“Accelerate your plant innovation!” VEGEPOLYS VALLEY is launching the 7th edition of its competition dedicated to start-ups.

MEET-UP Pharma: the 1st forum of the Healthcare Industry Professions in Auvergne.

Hypercholesterolemia: Valbiotis announces the major success of the Phase II HEART clinical study.

ON-LIGHT will take part on the 2nd Regional Research Days in the Hospital Centre, organized by Emile Roux Hospital Center of Puy-en-Velay on 23 and 24 June 2022.

Clermont Innovation Week Roundtable: How can and should health and climate-conscious agricultural approaches create value in our territories?

Le SMO Biopôle Clermont-Limagne publie son Panorama & chiffres Clés 2021.

Valbiotis announces approval to launch the two Phase II/III INSIGHT and INSIGHT 2 clinical studies, the last step in the development of TOTUM•854 for the reduction of blood pressure.

The EIB, with the support of the European Commission, is financing a €30 million loan for Carbios’ enzymatic recycling technology to support the Circular Economy.

STRAINCHEM enters the semi-industrial phase with France Relance.

Carbios receives support from the European Commission through the LIFE program.

Valbiotis: preclinical results for TOTUM•070 in hypercholesterolemia, selected and presented at the American Heart Association (AHA) annual meeting.

Pascal Mayer receives the prestigious breakthrough prize for his massive parallel sequencing technology codecovery.

Valbiotis obtains patent for its active substance TOTUM-63 in China.

Carbios and Michelin on their way to 100% sustainable tires.

With its extension project supported by France Relance, the Icare group strengthens its development ambitions.

Discover BIOLIFE ENTERPRISES special Biopôle Clermont-Limagne